NanoBio4Can Team Visits İLKO Pharmaceuticals

As part of the NanoBio4Can Industry Experience Days, NanoBio4Can MSCA Cofund project fellows, together with the project coordination team, had the pleasure of visiting the Biotechnology R&D Team at İLKO Pharmaceuticals, one of NanoBio4Can's official associated partners and a long-standing industrial partner of SUNUM, at Technopark Istanbul.

The team was warmly welcomed by Dilan Karabulut Bıçak, Biotechnology R&D Director, who delivered an insightful presentation on İLKO's biosimilar drug development activities. The presentation was followed by an engaging discussion with the fellows, after which she guided the group through the biotechnology laboratories, introducing İLKO's research capabilities and ongoing scientific activities.

İLKO Pharmaceuticals plays an important role in the program's intersectoral dimension by providing fellows with first-hand exposure to industrial biotechnology and biosimilar drug development in a real-world pharmaceutical R&D environment.

NanoBio4Can sincerely thanks the İLKO Pharmaceuticals team for their warm hospitality. We are especially grateful to Dilan Karabulut Bıçak for sharing her expertise and introducing the fellows to İLKO's biotechnology research and development activities. We also thank Sibel Bayram for coordinating the visit and Fatma Özlem Zurnacı Şanver for her support during the laboratory tour.

NanoBio4Can has received funding from the European Union (EU), Horizon Europe Research and Innovation Program under the Marie Skłodowska-Curie Actions (MSCA) – COFUND (Grant Agreement No. 101126492), and it is supported by the Scientific and Technological Research Council of Türkiye (TÜBİTAK) (Grant Agreement No. 123C460). Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the European Union or TÜBİTAK. Neither the European Union nor the granting authority can be held responsible for them.